N Bolokadze
- Co-authors
- Tengiz TsertsvadzeLali SharvadzeG. I. MchedlishviliNikoloz ChkhartishviliR ShakarishviliRevaz SolomoniaAmiran GamkrelidzeJack DeHovitz
- Topics
- Hepatitis C virus research (8 papers)HIV/AIDS Research and Interventions (7 papers)HIV/AIDS drug development and treatment (5 papers)
In The Last Decade
N Bolokadze
21 papers receiving 152 citations
Peers
Comparison fields: 5 of 51
- Epidemiology 94
- Infectious Diseases 87
- Virology 29
- Hepatology 23
- Physiology 18
Countries citing papers authored by N Bolokadze
This map shows the geographic impact of N Bolokadze's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by N Bolokadze with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites N Bolokadze more than expected).
Fields of papers citing papers by N Bolokadze
This network shows the impact of papers produced by N Bolokadze. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by N Bolokadze. The network helps show where N Bolokadze may publish in the future.
Co-authorship network of co-authors of N Bolokadze
This figure shows the co-authorship network connecting the top 25 collaborators of N Bolokadze. A scholar is included among the top collaborators of N Bolokadze based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with N Bolokadze. N Bolokadze is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 4 | |
| 2 | Uptake and outcomes of generic dolutegravir based antiretroviral therapy in Georgia | 0 |
| 3 | 1 | |
| 4 | 1 | |
| 5 | 1 | |
| 6 | 11 | |
| 7 | 1 | |
| 8 | 16 | |
| 9 | 3 | |
| 10 | INCIDENCE OF TUBERCULOSIS AMONG HIV/HCV CO-INFECTED PATIENTS RECEIVING HEPATITIS C TREATMENT WITH PEGYLATED INTERFERON AND RIBAVIRIN IN GEORGIA. | 4 |
| 11 | 18 | |
| 12 | 23 | |
| 13 | 4 | |
| 14 | Neurological complications in patients with HIV/AIDS. | 16 |
| 15 | Antiretroviral treatment in Georgia. | 1 |
| 16 | IFN/RBV treatment induced neutropenia and its correction with neupogen in patients with hepatitis C. | 8 |
| 17 | Comparison of erythrocyte aggregability changes during ischemic and hemorrhagic stroke. | 7 |
| 18 | Peculiarities of herpes zoster in immunocompetent and immunocompromised hosts. | 4 |
| 19 | Lipid peroxidation in the erythrocytes under condition of their increased aggregation. | 2 |
| 20 | About spread of local cerebral hemorheological disorders to whole body in critical care patients. | 9 |
About N Bolokadze
N Bolokadze is a scholar working on Hepatology, Virology and Infectious Diseases, having authored 22 papers that have together received 158 indexed citations. Recurring topics across this work include Hepatitis C virus research (8 papers), HIV/AIDS Research and Interventions (7 papers) and HIV/AIDS drug development and treatment (5 papers). The work is most often cited by research in Virology (29 citations), Infectious Diseases (87 citations) and Hepatology (23 citations). N Bolokadze has collaborated with scholars based in Georgia, Denmark and Romania. Frequent co-authors include Tengiz Tsertsvadze, Lali Sharvadze, G. I. Mchedlishvili, Nikoloz Chkhartishvili, R Shakarishvili, Revaz Solomonia, Amiran Gamkrelidze, Jack DeHovitz, Carlos del Rı́o and Akaki Abutidze. Their work appears in journals such as PLoS ONE, Journal of Medical Virology and AIDS Research and Human Retroviruses.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.